Teza Capital Management LLC acquired a new stake in Doximity, Inc. (NASDAQ:DOCS - Free Report) during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund acquired 38,090 shares of the company's stock, valued at approximately $2,034,000.
Several other institutional investors and hedge funds have also recently modified their holdings of the company. Global Retirement Partners LLC grew its stake in Doximity by 468.1% during the 4th quarter. Global Retirement Partners LLC now owns 534 shares of the company's stock worth $29,000 after purchasing an additional 440 shares in the last quarter. UMB Bank n.a. grew its stake in Doximity by 69.1% during the 4th quarter. UMB Bank n.a. now owns 575 shares of the company's stock worth $31,000 after buying an additional 235 shares during the last quarter. Larson Financial Group LLC grew its stake in Doximity by 49.4% during the 4th quarter. Larson Financial Group LLC now owns 756 shares of the company's stock worth $40,000 after buying an additional 250 shares during the last quarter. Optimum Investment Advisors acquired a new stake in Doximity during the 4th quarter worth approximately $43,000. Finally, Kapitalo Investimentos Ltda acquired a new stake in Doximity during the 4th quarter worth approximately $50,000. Hedge funds and other institutional investors own 87.19% of the company's stock.
Wall Street Analyst Weigh In
Several analysts have recently commented on the company. Raymond James reduced their price target on Doximity from $83.00 to $65.00 and set an "outperform" rating for the company in a report on Friday, May 16th. Mizuho cut their price target on Doximity from $65.00 to $60.00 and set a "neutral" rating for the company in a report on Friday, May 16th. Wells Fargo & Company reaffirmed an "equal weight" rating on shares of Doximity in a research report on Friday, February 7th. KeyCorp lowered their price objective on Doximity from $83.00 to $70.00 and set an "overweight" rating for the company in a research report on Wednesday, April 16th. Finally, Morgan Stanley reduced their target price on Doximity from $71.00 to $60.00 and set an "equal weight" rating on the stock in a report on Thursday, April 24th. Eleven equities research analysts have rated the stock with a hold rating, eight have issued a buy rating and two have assigned a strong buy rating to the stock. Based on data from MarketBeat.com, Doximity has a consensus rating of "Moderate Buy" and a consensus target price of $61.22.
Read Our Latest Research Report on DOCS
Insider Transactions at Doximity
In other news, Director Kira Scherer Wampler sold 2,000 shares of the stock in a transaction on Thursday, May 1st. The stock was sold at an average price of $56.93, for a total transaction of $113,860.00. Following the completion of the sale, the director now owns 16,618 shares in the company, valued at approximately $946,062.74. This represents a 10.74% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CFO Anna Bryson sold 45,000 shares of the stock in a transaction on Thursday, May 1st. The shares were sold at an average price of $57.23, for a total value of $2,575,350.00. Following the sale, the chief financial officer now owns 357,165 shares of the company's stock, valued at $20,440,552.95. This trade represents a 11.19% decrease in their position. The disclosure for this sale can be found here. Insiders own 37.40% of the company's stock.
Doximity Stock Performance
Shares of NASDAQ DOCS traded down $2.22 during midday trading on Wednesday, reaching $50.78. 4,029,532 shares of the company's stock were exchanged, compared to its average volume of 2,093,675. The stock has a market capitalization of $9.48 billion, a PE ratio of 50.78, a price-to-earnings-growth ratio of 4.10 and a beta of 1.41. Doximity, Inc. has a 52-week low of $25.00 and a 52-week high of $85.21. The business's fifty day moving average price is $57.04 and its two-hundred day moving average price is $57.99.
Doximity (NASDAQ:DOCS - Get Free Report) last posted its earnings results on Thursday, May 15th. The company reported $0.38 EPS for the quarter, beating the consensus estimate of $0.27 by $0.11. Doximity had a return on equity of 21.75% and a net margin of 36.60%. Doximity's quarterly revenue was up 17.1% compared to the same quarter last year. During the same quarter last year, the firm earned $0.25 earnings per share. Analysts predict that Doximity, Inc. will post 0.99 earnings per share for the current fiscal year.
Doximity Profile
(
Free Report)
Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.
Featured Stories

Before you consider Doximity, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Doximity wasn't on the list.
While Doximity currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.